“LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY: Gemtuzumab ozogamicin in AML” (2020) Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020020. doi:10.4084/mjhid.2020.020.